- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Recurrent Pregnancy Loss
Call for Papers
Spontaneous abortions are important causes of reproductive loss that are poorly understood and difficult to treat. First trimester pregnancy loss affects up to 15% of clinically recognized pregnancies. ‘Recurrent Pregnancy Loss’ (RPL) is defined as a ‘disease’ characterized by two or more failed pregnancies (Practice Committee of American Society for Reproductive Medicine, 2013). The true incidence of this condition is likely to be within the range of 1% and 5%, depending on adopted definition and studied population of women in the reproductive age.
Nowadays, RPL still represents a heterogeneous condition distressing for the patient and frustrating for the physician. The definition, diagnostic workup, and appropriate interventions among patients with RPL remain controversial.
Occurrence of more than 50% of RPL could not be detected by any available examination, including hysteroscopy, hysterosalpingography, antiphospholipid antibody testing, and parental karyotypes, and those cases were regarded as unexplained RPL.
Many authors studied the management of unexplained RPL, suggesting the use of progesterone, aspirin, low-molecular-weight heparin (LMWH), and human chorionic gonadotropin (hCG). Lines of evidence on their efficacy are limited, and the optimal management of these patients is still unclear.
A better knowledge and understanding of this condition would lead to the development of an evidence-based approach in management and counseling in women who experience recurrent miscarriages.
We invite investigators to contribute original research articles as well as review articles that will stimulate the continuing efforts to understand the pathophysiology of RPL and thus the development of strategies to treat this condition. Potential topics include, but are not limited to:
- Epidemiology and risk factors
- Assessment and investigations of couples with recurrent miscarriage
- Advances in molecular genetics and molecular diagnostics
- Treatment options
- Recent developments in recurrent miscarriage research
- Preimplantation genetic screening with in vitro fertilization treatment
Before submission authors should carefully read over the journal’s Author Guidelines which are located at http://www.hindawi.com/journals/ogi/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/ogi/rcpl/ according to the following timetable:
|Manuscript Due||Friday, 4 October 2013|
|First Round of Reviews||Friday, 27 December 2013|
|Publication Date||Friday, 21 February 2014|
Lead Guest Editor
- Coccia Maria Elisabetta, Department of Clinical and Experimental Biomedical Sciences, University of Florence, Florence, Italy
- Carlo Bulletti, 'Cervesi' Hospital Cattolica, IVF Unit, Cattolica, Italy
- Jose Remohi, Universitat de Valencia, Valencia, Spain
- Dominique De Ziegler, Hôpitaux Universitaires de Genève, Department of Obstetrics and Gynecology, Geneva, Switzerland
- Tullia Todros, University of Turin, Maternal-Fetal Medicine Unit, Turin, Italy